GPC Biotech AG is a biopharmaceutical company, which is engaged in the discovery, development and commercialization of anticancer drugs. Its lead product candidate is satraplatin, a platinum-based compound intended for use as a chemotherapy treatment. Unlike other platinum-based drugs,... more

Nastech is a clinical stage biopharmaceutical company focusing on the development and commercialization of innovative therapeutic products based on our proprietary molecular biology-based drug delivery technologies and our proprietary ribonucleic acid interference technology. Nastech and... more

Albany Molecular Research, Inc. provides scientific services, technologies and products. The Company's core business consists of a fee-for-service contract services platform encompassing drug discovery, development and manufacturing, and a separate, stand-alone research and development... more

Pharmacopeia, Inc. is a clinical development stage biopharmaceutical company dedicated to discovering and developing small molecule therapeutics to address medical needs. It has a portfolio of clinical and preclinical candidates under development internally or by partners, including eight... more

Isis Pharmaceuticals, Inc. (Isis) is a biopharmaceutical company engaged in antisense technology, exploiting a drug discovery platform to create a pipeline of drugs. In addition to its antisense programs, the Company maintains technology leadership beyond its core areas of focus through... more

Icagen, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of orally administered small molecule drugs that modulate ion channel targets. The Company has identified drug candidates that modulate ion channels. Its two most advanced programs are... more

The Company was originally founded in 1987 with the objective of developing proprietary drug discovery technologies based on naturally occurring plants and organisms. Investment was made in selected target technologies, particularly in the cancer and cardiovascular therapeutic areas. As... more

Axys Pharmaceuticals, Inc. is an integrated small molecule drug discovery and development company. Axys has a broad pipeline of products for chronic therapeutic applications that are partnered with world-class pharmaceutical companies and a proprietary product portfolio in oncology. Axys... more

ChemCodes has developed a proprietary high throughput medicinal chemistry discovery and development platform that provides benefits of speed, diversity and quality which results in chemistry with better performance and small molecule development in a faster time period accomplished at a... more

Ercole is developing a new class of drugs that modulate alternative splicing -- a natural gene regulatory mechanism. Ercole believes its technology is applicable to several major diseases, include cancer, inflammatory diseases and cardiovascular disorders.

Vipergen is a biotech start-up company pioneering the successful implementation of small molecule DNA-display with its proprietary and cutting edge YoctoReactor® Technology. Vipergen aims to be the partner of choice in early-phase small molecule drug discovery efforts. Vipergen is... more